212 related articles for article (PubMed ID: 29649025)
1. Risk of Anal Cancer in Women With a Human Papillomavirus-Related Gynecological Neoplasm: Puerto Rico 1987-2013.
Acevedo-Fontánez AI; Suárez E; Torres Cintrón CR; Ortiz AP
J Low Genit Tract Dis; 2018 Jul; 22(3):225-230. PubMed ID: 29649025
[TBL] [Abstract][Full Text] [Related]
2. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
[TBL] [Abstract][Full Text] [Related]
3. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
4. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
5. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
6. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
Saleem AM; Paulus JK; Shapter AP; Baxter NN; Roberts PL; Ricciardi R
Obstet Gynecol; 2011 Mar; 117(3):643-649. PubMed ID: 21343768
[TBL] [Abstract][Full Text] [Related]
7. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
8. HPV-related cancers after solid organ transplantation in the United States.
Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA
Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294
[TBL] [Abstract][Full Text] [Related]
9. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
10. Anal cancer incidence and mortality in Puerto Rico.
Colón-López V; Ortiz AP; Soto-Salgado M; Torres-Cintrón M; Mercado-Acosta JJ; Suárez E
P R Health Sci J; 2013 Jun; 32(2):76-81. PubMed ID: 23781623
[TBL] [Abstract][Full Text] [Related]
11. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
[TBL] [Abstract][Full Text] [Related]
12. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women.
Heard I; Etienney I; Potard V; Poizot-Martin I; Moore C; Lesage AC; Ressiot E; Crenn-Hebert C; Fléjou JF; Cubie H; Costagliola D; Darragh TM;
Clin Infect Dis; 2015 May; 60(10):1559-68. PubMed ID: 25645213
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
15. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
[TBL] [Abstract][Full Text] [Related]
16. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
17. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe.
Škamperle M; Kocjan BJ; Maver PJ; Seme K; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):1-5. PubMed ID: 23674179
[TBL] [Abstract][Full Text] [Related]
20. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
